Abooali, Maryam (2015) Crucial involvement of xanthine oxidoreductase in the biological responses of myeloid hematopoietic cells. Doctor of Philosophy (PhD) thesis, University of Kent. (Access to this publication is currently restricted. You may be able to access a copy if URLs are provided) (KAR id:49841)
PDF
Language: English Restricted to Repository staff only |
|
Contact us about this Publication
|
![]() |
Abstract
Xanthine oxidoreductase (XOR) is one of the main purine catabolising enzymes which converts hypoxanthine into xanthine and further into uric acid. The enzyme has a homodimeric structure and contains two FeS centres, one FAD molecule and one molybdenum atom per monomer. Recent evidence clearly demonstrated that XOR activity is highly increased in human hematopoietic cells of myeloid lineage during their pathogen-induced and endogenously generated biological responses. The integrative signalling role and especially involvement of XOR in cross-talk of metabolic and signalling machinery of human leukocytes remains poorly understood.
Findings reported in this thesis open a new field in human myeloid cell research and translational medicine. XOR is an easily accessible therapeutic target, which could be pharmacologically corrected using non-toxic drugs.
Item Type: | Thesis (Doctor of Philosophy (PhD)) |
---|---|
Thesis advisor: | Sumbayev, Vadim |
Thesis advisor: | Gibbs, Bernhard |
Uncontrolled keywords: | AP-1 – Activating Protein-1 HIF-1 – Hypoxia-Inducible Factor 1 mTOR – Mammalian target of rapamycin XOR – Xanthine oxidoreductase |
Subjects: | R Medicine > RS Pharmacy and materia medica |
Divisions: | Divisions > Division of Natural Sciences > Medway School of Pharmacy |
Depositing User: | Users 1 not found. |
Date Deposited: | 27 Jul 2015 11:00 UTC |
Last Modified: | 16 Feb 2021 13:26 UTC |
Resource URI: | https://kar.kent.ac.uk/id/eprint/49841 (The current URI for this page, for reference purposes) |
- Export to:
- RefWorks
- EPrints3 XML
- BibTeX
- CSV
- Depositors only (login required):